ArticleJournal of cancer survivorship : research and practice2019

Risk of dementia among postmenopausal breast cancer survivors treated with aromatase inhibitors versus tamoxifen: a cohort study using primary care data from the UK.

Susan E Bromley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.